Ovid Therapeutics Ownership | Who Owns Ovid Therapeutics?

Overview Forecast RevenueFinancials Chart

Ovid Therapeutics Ownership Summary

Ovid Therapeutics is owned by 54.43% institutional investors, 15.91% insiders, and 29.66% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 7.52% of OVID shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Ovid Therapeutics shares.

OVID Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ovid Therapeutics	54.43%	15.91%	29.66%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rubric capital management lp	5.32M	7.52%	$4.09M
Madison avenue partners, lp	4.08M	5.77%	$3.14M
Blackrock	3.99M	5.65%	$3.07M
Bvf inc/il	3.85M	5.45%	$2.96M
Vanguard group	3.09M	4.37%	$2.38M
Artal group	2.50M	3.54%	$1.92M
Acadian asset management	1.66M	2.35%	$1.28M
Kennedy capital management	1.49M	2.10%	$1.15M
Jpmorgan chase	1.47M	2.07%	$1.13M
Driehaus capital management	1.40M	1.98%	$1.08M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tls advisors	1.13M	2.17%	$866.00K
Madison avenue partners, lp	4.08M	0.40%	$3.14M
Prosight management, lp	1.07M	0.25%	$826.89K
Rubric capital management lp	5.32M	0.11%	$4.09M
Bvf inc/il	3.85M	0.08%	$2.96M
Artal group	2.50M	0.05%	$1.92M
Kennedy capital management	1.49M	0.02%	$1.15M
Tejara capital	68.52K	0.02%	$52.70K
Dcf advisers	41.75K	0.02%	$32.11K
Ubs oconnor	288.29K	0.01%	$221.69K

Top Buyers

Holder	Shares	% Assets	Change
Kennedy capital management	1.49M	0.02%	1.49M
Driehaus capital management	1.40M	0.01%	1.40M
Madison avenue partners, lp	4.08M	0.40%	433.59K
Wells fargo & company/mn	741.64K	0.00%	307.77K
State street	1.35M	-	198.72K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-6.12M
Blue owl capital lp	-	-	-864.82K
Fft wealth management	-	-	-489.55K
Blackrock	3.99M	0.00%	-202.94K
Tls advisors	1.13M	2.17%	-194.38K

New Positions

Holder	Shares	% Assets	Change	Value
Kennedy capital management	1.49M	0.02%	1.49M	$1.15M
Driehaus capital management	1.40M	0.01%	1.40M	$1.08M
Gsa capital partners llp	119.51K	0.01%	119.51K	$92.00K
Alliancebernstein	47.88K	-	47.88K	$36.83K
Corebridge financial	31.68K	0.00%	31.68K	$24.37K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-10.00
Qube research	-54.00
Ica group wealth management	-55.00
Metropolitan life insurance co/ny	-977.00
Federated hermes	-2.25K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	74	-8.64%	38,492,740	-9.60%	54	1.50%	36	-5.26%	25	4.17%
Mar 31, 2024	81	5.19%	42,579,420	-3.51%	60	1.55%	38	-7.32%	24	41.18%
Dec 31, 2023	77	20.31%	44,126,877	4.21%	62	1.73%	41	78.26%	17	-15.00%
Sep 30, 2023	64	-9.86%	42,343,665	3.26%	60	1.77%	23	-48.89%	20	42.86%
Jun 30, 2023	71	14.52%	41,007,449	5.98%	58	1.93%	45	87.50%	14	-6.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.79M	2.53%	-
iShares Russell 2000 ETF	1.61M	2.26%	-3.61K
Kennedy Micro Cap	1.13M	1.59%	-14.30K
Vanguard Institutional Extnd Mkt Idx Tr	819.59K	1.15%	-
Fidelity Small Cap Index	635.37K	0.90%	-2.15K
JPMorgan US Small Company L	559.53K	0.79%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	537.80K	0.76%	-12.10K
iShares Russell 2000 Growth ETF	519.91K	0.73%	-
MEDICAL BioHealth EUR Acc	503.85K	0.71%	-
iShares Biotechnology ETF	405.49K	0.57%	-2.42K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 18, 2024	LEVIN JEREMY M	CEO	Buy	$50.36K
Sep 12, 2022	Tardio Jason	Chief Operating Officer	Sell	$37.29K
Jul 14, 2021	Rakhit Amit	President and CMO	Sell	$126.20K
Aug 28, 2020	LEVIN JEREMY M	CEO	Buy	$49.57K
Oct 08, 2019	TAKEDA PHARMACEUTICAL CO LTD	-	Buy	$5.00M

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q1	1	-
2023 Q4	-	-
2023 Q1	-	-
2022 Q3	-	1

OVID Ownership FAQ

Who Owns Ovid Therapeutics?

Ovid Therapeutics shareholders are primarily institutional investors at 54.43%, followed by 15.91% insiders and 29.66% retail investors. The average institutional ownership in Ovid Therapeutics's industry, Biotech Stocks , is 44.97%, which Ovid Therapeutics exceeds.

Who owns the most shares of Ovid Therapeutics?

Ovid Therapeutics’s largest shareholders are Rubric capital management lp (5.32M shares, 7.52%), Madison avenue partners, lp (4.08M shares, 5.77%), and Blackrock (3.99M shares, 5.65%). Together, they hold 18.94% of Ovid Therapeutics’s total shares outstanding.

Does Blackrock own Ovid Therapeutics?

Yes, BlackRock owns 5.65% of Ovid Therapeutics, totaling 3.99M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.07M$. In the last quarter, BlackRock decreased its holdings by -203K shares, a -4.84% change.

Who is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested?

Tls advisors is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.17% of its assets in 1.13M Ovid Therapeutics shares, valued at 866K$.

Who is the top mutual fund holder of Ovid Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Ovid Therapeutics shares, with 2.53% of its total shares outstanding invested in 1.79M Ovid Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools